Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
about
Ziprasidone versus other atypical antipsychotics for schizophreniaAmisulpride versus other atypical antipsychotics for schizophreniaHostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesEfficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic ReviewEffectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Friends and symptom dimensions in patients with psychosis: a pooled analysis.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Pathways to aggression in schizophrenia affect results of treatmentQuantifying clinical relevance in the treatment of schizophrenia.The psychopharmacology of violence: making sensible decisions.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.From Clozapine to Cognitive Remediation.Aggression in Psychoses
P2860
Q24240260-0D62B96D-7230-4A9C-839B-9460EA5E5FF9Q24240433-50BBF7FF-DB56-496D-BBDC-8EA6F3EDEFDFQ24289439-757F33C4-E677-4C26-B0B2-3373CB33C758Q33695789-A2ED5D2D-03D1-4E2F-80E2-3E691DA83006Q33826250-81EE3621-FDE2-4091-9DF1-2CE44A3E3DB8Q34274859-DEDFAEDD-EF00-42B8-97A9-C8D580B09C64Q34491079-43618F1F-ADAA-4D24-97A8-FBCBE16E852AQ34640811-803026E8-04DD-4D53-88A9-EB3872E63944Q35177162-DAF2F868-C548-4503-8109-89B9662A4689Q35819467-24A54C9F-E035-4D81-99BA-F97CE07BF50BQ38191300-DBA657E1-DAB1-43CF-8D25-6D6BBB514D4EQ38473914-E0EE7B4B-BB62-456D-907C-A404F4BAD2CBQ41078160-2EC5266E-D394-4CD6-9055-2EC77A98810BQ41904519-497BF4AA-E89F-47DD-9D22-AA3E3800DCE5Q59048862-1A833CA5-C1BA-4465-A810-6777FB3791CC
P2860
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efficacy of antipsychotic drug ...... Schizophrenia Trial (EUFEST).
@en
type
label
Efficacy of antipsychotic drug ...... Schizophrenia Trial (EUFEST).
@en
prefLabel
Efficacy of antipsychotic drug ...... Schizophrenia Trial (EUFEST).
@en
P2093
P50
P356
P1476
Efficacy of antipsychotic drug ...... Schizophrenia Trial (EUFEST).
@en
P2093
EUFEST Study Group
Jan Volavka
Pal Czobor
W Wolfgang Fleischhacker
P304
P356
10.4088/JCP.10M06529
P577
2011-07-01T00:00:00Z